About Mountain Comprehensive Healthcare Corporation
Mountain Comprehensive Healthcare Corporation offers medical services, including family practice, internal medicine, pulmonology, pediatrics, and more. It is based in Whitesburg, Kentucky.
Missing: Mountain Comprehensive Healthcare Corporation's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Mountain Comprehensive Healthcare Corporation's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Mountain Comprehensive Healthcare Corporation News
Apr 18, 2022
Pear to host panel discussion with leaders who are paving the way to provide patients access to prescription digital therapeutics for the treatment of substance use and opioid use disorders April 18, 2022 06:30 AM Eastern Daylight Time BOSTON--( BUSINESS WIRE )-- Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will host an educational Vision Session at the Rx and Illicit Drug Summit (Rx Summit), April 18-21 in Atlanta, GA. The Rx Summit is the largest annual gathering for global stakeholders to address the opioid and addiction epidemic and share best practices and strategies for prevention, treatment, and recovery. “The US has seen an unprecedented increase in drug use and overdose deaths during the COVID-19 pandemic, exacerbated by challenges for people living in isolation or with few viable treatment resources available,” said Yuri Maricich, MD, MBA, Chief Medical Officer, Pear Therapeutics. “At this year’s Rx Summit, we look forward to discussing with our clinician panelists how PDTs can address health equity and health care disparities, potentially improve treatment outcomes, and expand access to proven treatment options for people living with addiction. The Vision Session, titled “Recovery is in Your Hands: How Access to Digital Therapeutics Can Drive Outcomes” will feature a presentation and panel discussion including decision makers who are leading the way to provide access to PDTs. The session will highlight how PDTs for substance use disorder (SUD) and opioid use disorder (OUD) are working to improve access to care for patients, including underserved populations, explore clinical outcomes and real-world engagement data, and discuss how various organizations and key decision makers can pave the way with digital treatments to treat serious diseases. Panel participants will include: Shawn Ryan, MD, MBA; President and Chief Medical Officer, BrightView Health Timothy Aungst, PharmD; Associate Professor at MCPHS University, Worcester, MA, and Clinical Pharmacist in home health care. Sonji Adams, LPCC, LCADC; Behavioral Health Coordinator, Mountain Comprehensive Health Corporation George Kitchens, RPh; CEO, Artia Solutions and Former Pharmacy Services Bureau Chief, FL Medicaid Pear Therapeutics is the category creator and leader in PDTs, having developed the first and only FDA-authorized PDTs to treat SUD and OUD. PDTs are a new therapeutic class that uses software to treat serious disease. Like traditional medicines, PDTs are developed in a GMP-compliant environment, tested in randomized controlled trials to demonstrate safety and effectiveness, evaluated for authorization by regulators like FDA, and used under the supervision of a prescribing clinician. Unlike traditional medicines, PDTs are designed to collect real world data for use by prescribing clinicians and for population health management by payers and health systems. To learn more about the Session, which will take place on Tuesday, April 19 at 8:00 ET in International Ballroom A-D, please visit www.rx-summit.com/agenda . For more information on Pear’s PDTs for SUD and OUD, visit www.resetforrecovery.com . About Pear Therapeutics Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. Pear’s product, reSET®, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Pear’s second product, reSET-O®, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear’s third product, Somryst® for the treatment of chronic insomnia, was the first PDT submitted through FDA’s traditional 510(k) pathway while simultaneously reviewed through FDA’s Software Precertification Pilot Program. For more information, visit Pear at www.peartherapeutics.com . reSET Important Safety Information Indications for Use: reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older, who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 day) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to:
Mountain Comprehensive Healthcare Corporation Frequently Asked Questions (FAQ)
Where is Mountain Comprehensive Healthcare Corporation's headquarters?
Mountain Comprehensive Healthcare Corporation's headquarters is located at 10 East Main Street – Suite A, Whitesburg.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.